| ²é¿´: 470 | »Ø¸´: 4 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
lvlingziÒø³æ (СÓÐÃûÆø)
|
[½»Á÷]
¼¸Æª¹ØÓÚÇå½àÑéÖ¤µÄÓ¢ÎÄÎÄÏ×
|
||
|
°üÀ¨£º Application of Visible-Residue Limit for Cleaning Validation in a Pharmaceutical Manufacturing Facility Cleaning Validation for Developmental, Stability, and Clinical Lots Design of good cleaning processes key in pharmaceutical validation and compliance Dispelling Cleaning Validation Myths Part I Dispelling Cleaning Validation Myths Part II Market Profile Cleaning Validation Techniques Pursuing Efficiency-New developments in cleaning technology Risk-Management Assessment of Visible-Residue Limits in Cleaning Validation Swab Sampling for Cleaning Validation Validation of a Clean-in-Place System on a Capsule Filling Machine Visible-Residue Limit for Cleaning Validation and its potential Application in a Pharmaceutical Research Facility ²»ÖªµÀ´ó¼ÒÊÇ·ñÓÐÐËȤ£¿ [ Last edited by lvlingzi on 2007-7-20 at 10:15 ] |
» ²ÂÄãϲ»¶
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ162È˻ظ´
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
Éú·À¾úµÄÅèÔÔ·ÀЧʵÑé
ÒѾÓÐ1È˻ظ´
Çë½Ì´óÀÐÀ©É¢ÎÊÌâ
ÒѾÓÐ5È˻ظ´
¹òÇóÒ»Ö§AAV293ϸ°û
ÒѾÓÐ1È˻ظ´
ÖÐÎÄͶ¸å¡°Ö×ÁöÃâÒß¡±Ïà¹Ø
ÒѾÓÐ6È˻ظ´
2025ÄêҩѧרҵÇóµ÷¼Á
ÒѾÓÐ1È˻ظ´
292ҩѧµ÷¼Á
ÒѾÓÐ1È˻ظ´
¿´¹ýÍù²¡Àú£¬ÓÐÒÉ»óÇë½Ì
ÒѾÓÐ1È˻ظ´
lvlingzi
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 373.9
- ºì»¨: 1
- Ìû×Ó: 70
- ÔÚÏß: 21.1Сʱ
- ³æºÅ: 99487
- ×¢²á: 2005-11-11
- ÐÔ±ð: MM
- רҵ: Ò©ÎïѧÆäËû¿ÆÑ§ÎÊÌâ
2Â¥2007-07-21 23:56:09
yanzr
Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 9399
- ºì»¨: 2
- Ìû×Ó: 6335
- ÔÚÏß: 537.7Сʱ
- ³æºÅ: 108244
- ×¢²á: 2005-11-18
- ÐÔ±ð: GG
- רҵ: ÉúÎﻯѧ
3Â¥2007-07-22 09:41:49









»Ø¸´´ËÂ¥

30